000063233 001__ 63233
000063233 005__ 20171117104915.0
000063233 0247_ $$2doi$$a10.1097/MD.0000000000000746
000063233 0248_ $$2sideral$$a90305
000063233 037__ $$aART-2015-90305
000063233 041__ $$aeng
000063233 100__ $$aBarbosa, I.R.
000063233 245__ $$aCancer mortality in Brazil: Temporal trends and predictions for the year 2030
000063233 260__ $$c2015
000063233 5060_ $$aAccess copy available to the general public$$fUnrestricted
000063233 5203_ $$aCancer is currently in the spotlight due to their heavy responsibility as main cause of death in both developed and developing countries. Analysis of the epidemiological situation is required as a support tool for the planning of public health measures for the most vulnerable groups. We analyzed cancer mortality trends in Brazil and geographic regions in the period 1996 to 2010 and calculate mortality predictions for the period 2011 to 2030. 
This is an epidemiological, demographic-based study that utilized information from the Mortality Information System on all deaths due to cancer in Brazil. Mortality trends were analyzed by the Joinpoint regression, and Nordpred was utilized for the calculation of predictions. 
Stability was verified for the female (annual percentage change [APC] = 0.4%) and male (APC = 0.5%) sexes. The North and Northeast regions present significant increasing trends for mortality in both sexes. Until 2030, female mortality trends will not present considerable variations, but there will be a decrease in mortality trends for the male sex. There will be increases in mortality rates until 2030 for the North and Northeast regions, whereas reductions will be verified for the remaining geographic regions. This variation will be explained by the demographic structure of regions until 2030. 
There are pronounced regional and sex differences in cancer mortality in Brazil, and these discrepancies will continue to increase until the year 2030, when the Northeast region will present the highest cancer mortality rates in Brazil.
000063233 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000063233 590__ $$a1.206$$b2015
000063233 591__ $$aMEDICINE, GENERAL & INTERNAL$$b78 / 153 = 0.51$$c2015$$dQ3$$eT2
000063233 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000063233 700__ $$aDe Souza, D.L.B.
000063233 700__ $$0(orcid)0000-0002-9657-3799$$aBernal, M.M.$$uUniversidad de Zaragoza
000063233 700__ $$aDo C.C. Costa, I.
000063233 7102_ $$11008$$2615$$aUniversidad de Zaragoza$$bDepartamento de Microbiología, Medicina Preventiva y Salud Pública$$cMedicina Preventiva y Salud Pública
000063233 773__ $$g94, 16 (2015),  [6 pp]$$pMedicine (Baltim.)$$tMedicine (Baltimore)$$x0025-7974
000063233 8564_ $$s163128$$uhttps://zaguan.unizar.es/record/63233/files/texto_completo.pdf$$yVersión publicada
000063233 8564_ $$s8524$$uhttps://zaguan.unizar.es/record/63233/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000063233 909CO $$ooai:zaguan.unizar.es:63233$$particulos$$pdriver
000063233 951__ $$a2017-11-16-13:54:59
000063233 980__ $$aARTICLE